DBD vs NCNO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NCNO Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to nCino, Inc. Common Stock (NCNO) driven by superior Momentum & Technical, Options & Structure while DBD counters with relative strength in Valuation, Growth & Margin. Fundamentally, DBD trades at 8.6x Forward P/E with 9.0% operating margin (+5.2% YoY revenue) versus NCNO at 22.2x Forward P/E and 8.2% operating margin (+8.2% YoY). In options structure, DBD sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro) against NCNO sits in CONSOLIDATION (20th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | DBD Revenue | NCNO Revenue | DBD Op. Margin | NCNO Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $4.41B | N/A | -0.6% | N/A | DBD |
| FY2020 | $3.90B | $140M | 0.6% | -20.4% | DBD |
| FY2021 | $3.91B | $200M | 3.5% | -20.9% | DBD |
| FY2022 | $3.46B | $270M | -6.1% | -26.1% | DBD |
| FY2023 | N/A | $410M | N/A | -23.0% | NCNO |
| FY2024 | $3.75B | $480M | 4.9% | -8.3% | DBD |
| FY2025 | $3.81B | $540M | 6.4% | -3.4% | DBD |
| FY2026 | N/A | $590M | N/A | 0.6% | NCNO |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DBD | NCNO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.8B | $2.4B | Larger Scale | NCNO |
| Trailing P/E Ratio Valuation | 26.1x | 71.1x | Lower Multiple | DBD |
| Forward P/E Ratio Valuation | 8.6x | 22.2x | Lower Multiple | DBD |
| Revenue Growth (YoY) Growth | +5.2% | +8.2% | Higher Growth | NCNO |
| Operating Margin (TTM) Profitability | 9.0% | 8.2% | Higher Margin | DBD |
| Net Profit Margin Profitability | 2.0% | 5.4% | Higher Margin | NCNO |
| Return on Equity (ROE) Capital Efficiency | 7.7% | 3.9% | Higher ROE | DBD |
| 52-Week Range Position Momentum | 2% ($52โ$92) | 62% ($14โ$28) | Stronger Trend | NCNO |
| Beta / 30D Volatility Risk Regime | 1.02ฮฒ ยท 59% Vol | 0.40ฮฒ ยท 38% Vol | Lower Realized Risk | NCNO |
| Unified Institutional Score Composite Signal | 41.7 / 100 (SELL) | 54.6 / 100 (HOLD) | Higher Composite | NCNO |